ArticleJournal of nanobiotechnology2026
A bioadhesive antioxidant dual-crosslinked hydrogel mitigates endothelial pyroptosis to enhance ischemic flap survival.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Multiterritory perforator flaps are widely used in reconstructive surgery; however, distal regions, particularly the choke zone, remain highly susceptible to necrosis due to sustained ischemia, oxidative stress, and endothelial inflammatory injury that impair microcirculatory remodeling. Although stem cell-derived exosomes are promising cell-free therapeutics, their efficacy in ischemic flaps is often limited by poor local retention and rapid loss of bioactivity. Here, we develop a bioadhesive antioxidant hydrogel composed of oxidized hyaluronic acid-dopamine and sericin methacrylate (SerMA) to enable stable wet-tissue adhesion and sustained local delivery of hypoxia-preconditioned adipose-derived stem cell exosomes. This strategy attenuates oxidative stress, suppresses NLRP3 inflammasome activation and endothelial pyroptosis, and preserves mitochondrial and angiogenic function under ischemic conditions. In a rat multiterritory perforator flap model, local application of the exosome-loaded hydrogel significantly enhanced flap perfusion and survival, promoted vascular remodeling within the choke zone, and reduced inflammatory responses. Transcriptomic analysis further revealed suppression of inflammasome-associated pathways and enrichment of vascular remodeling programs. Collectively, this work presents a bioadhesive hydrogel-based exosome delivery strategy that stabilizes the ischemic microenvironment and improves outcomes in complex perforator flap reconstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.